Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Neglected Tropical Disease Treatment Market Evolve in Terms of Growth and Size by 2029?

The market for treating neglected tropical diseases has seen robust expansion in the past years. It is projected to increase from $3.36 billion in 2024 to $3.57 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Contributing factors to this growth during the historical period include enhanced attention from governments towards disease eradication programs, a rise in public-private collaboration for medication contributions, an uptick in pharmaceutical donations by worldwide drug producers, amplified research into cost-effective antiparasitic therapies, and escalated investment in the development of vaccines and diagnostics.

The market size for the treatment of neglected tropical diseases is predicted to significantly enlarge in the forthcoming years. Its value is expected to hit $4.52 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.1%. This growth over the forecast period can be attributed to the increased use of digital tools for disease monitoring, a robust pipeline of new treatments and vaccines, mounting pressure to tackle antimicrobial resistance, enhanced cross-border cooperation for disease eradication, and the rising disease spread due to climate change. Key trends in this period are expected to be the development of localized treatment methods, the creation of cost-effective vaccine platforms, the merger with primary healthcare systems, the amalgamation of disease surveillance networks, and innovation in vector control solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24616&type=smp

What factors are expected to fuel Neglected Tropical Disease Treatment market growth in the coming years?

The increasing occurrence of infectious diseases is anticipated to drive the expansion of the neglected tropical disease treatment market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can transmit directly or indirectly between individuals. The upsurge in these diseases is attributed to the rise in travel, enabling the swift transmission of pathogens across international borders. Neglected tropical disease treatments play a significant role in managing infectious diseases by offering specialized therapies to control and eradicate the spread of diseases. These treatments enhance public health consequences, particularly in susceptible communities, by lowering the disease load and preventing prolonged disabilities. For example, the UK Health Security Agency, a UK government agency, reported in February 2024 that tuberculosis cases in England escalated to 4,850 in 2023, marking a growth of 10.7% from 4,380 cases in 2022. Consequently, the escalating occurrence of infectious diseases is contributing to the growth of the neglected tropical disease treatment market.

What Are The Key Findings From The Segmentation Analysis Of The Neglected Tropical Disease Treatment Market?

The neglected tropical disease treatment market covered in this report is segmented –

1) By Drug Class: Anti-Parasite, Antifungal, Antibiotics, Other Drugs Class

2) By Disease Type: Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Other Disease Types

3) By Route of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospital, Specialty Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Anti-Parasite: Anthelmintics, Antiprotozoals, Antimalarials, Ectoparasiticides

2) By Antifungal: Azoles, Polyenes, Allylamines, Echinocandins

3) By Antibiotics: Tetracyclines, Macrolides, Rifamycins, Sulfonamides

4) By Other Drug Classes: Antivirals, Corticosteroids, Combination Therapies, Supportive Treatments

Which Trends Are Expected To Shape The Future Of The Neglected Tropical Disease Treatment Market?

Companies in the forefront of neglected tropical disease treatment are centering their objectives around strategic capital infusion to boost R&D, increase global availability and enhance innovative treatment strategies. The neglected tropical disease treatment market is being advanced due to these strategic investments which fund research advancements, cultivate partnerships and expedite the creation of effective, affordable treatments for populations lacking adequate healthcare. For example, a Swiss pharmaceutical firm, Novartis AG, in June 2022, allocated a substantial amount of $250 million towards combating neglected tropical diseases (NTDs) and malaria. This allocation is intended to improve the accessibility of treatments in poorer regions and prop up the creation of novel treatments for neglected tropical diseases.

What Are The Most Active Companies In The Neglected Tropical Disease Treatment Market Today?

Major companies operating in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy`s Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., Medicines Development for Global Health Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neglected-tropical-disease-treatment-global-market-report

Which Regional Markets Are Attracting The Most Investment In Neglected Tropical Disease Treatment?

Asia-Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in the neglected tropical disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24616&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model